These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21997126)

  • 1. Dual properties of anticancer agents: an exploratory study on the in vitro anti-Candida properties of thirty drugs.
    Routh MM; Raut JS; Karuppayil SM
    Chemotherapy; 2011; 57(5):372-80. PubMed ID: 21997126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential fungicidal effect of voriconazole against Candida spp.
    Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
    Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of plant oils as inhibitors of Candida albicans growth.
    Devkatte AN; Zore GB; Karuppayil SM
    FEMS Yeast Res; 2005 Jun; 5(9):867-73. PubMed ID: 15925315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.
    Zore GB; Thakre AD; Rathod V; Karuppayil SM
    Mycoses; 2011 Jul; 54(4):e99-109. PubMed ID: 20337938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
    Zore GB; Thakre AD; Jadhav S; Karuppayil SM
    Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer Drugs as Antibiofilm Agents in Candida albicans: Potential Targets.
    Wakharde AA; Halbandge SD; Phule DB; Karuppayil SM
    Assay Drug Dev Technol; 2018 Jul; 16(5):232-246. PubMed ID: 29446984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
    Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
    Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
    Vardar-Unlu G; Yağmuroğlu A; Unlu M
    Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
    Wei GX; Bobek LA
    J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing Candida isolates with low-high phenotype.
    Alp S; Sancak B; Hascelik G; Arikan S
    Mycoses; 2010 Nov; 53(6):475-80. PubMed ID: 19563491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
    Lignell A; Löwdin E; Cars O; Sjölin J
    J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
    Messier C; Grenier D
    Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effectiveness of mouthrinses against Candida albicans.
    Nakamoto K; Tamamoto M; Hamada T
    Int J Prosthodont; 1995; 8(5):486-9. PubMed ID: 8595107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibilities to yeasts using the ATB FUNGUS 2 method, compared with Sensititre Yeast One and standard CLSI (NCCLS) M27-A2 methods.
    Torres-Rodríguez JM; Alvarado-Ramírez E
    J Antimicrob Chemother; 2007 Sep; 60(3):658-61. PubMed ID: 17623690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activity of the amyrin derivatives and in vitro inhibition of Candida albicans adhesion to human epithelial cells.
    Johann S; Soldi C; Lyon JP; Pizzolatti MG; Resende MA
    Lett Appl Microbiol; 2007 Aug; 45(2):148-53. PubMed ID: 17651210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
    De Seta F; Schmidt M; Vu B; Essmann M; Larsen B
    J Antimicrob Chemother; 2009 Feb; 63(2):325-36. PubMed ID: 19059942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of dialkylphosphocholines.
    Lukác M; Mrva M; Fischer-Fodor E; Lacko I; Bukovský M; Miklásová N; Ondriska F; Devínsky F
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6346-9. PubMed ID: 19818608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].
    Kurnatowska AK; Kwaśniewska J
    Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.
    Tandon VK; Yadav DB; Chaturvedi AK; Shukla PK
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3288-91. PubMed ID: 15913995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.